Nivolumab,Ipilimumab,Pembrolizumab,Durvalumab,Toripalimab,Atezolizumab,carboplatin,gemcitabine,paclitaxel,nab-paclitaxel,cisplatin,docetaxel,pemetrexed
BMS,Merck,Astrazeneca,Coherus,Junshi Biosciences,Roche
['lcsm,(-blcsm)']
dr. raising many important questions regarding tx with peri-op #io. impact of adjuvant io after neoadjuvant chemoio needs to be studied further #asco23 #lcsm 
#HemeOnc @LombardiCancer |@EmoryDeptofMed @GradyHealth @tulanemedicine |#MedEd #clinicaltrials #disparities #lcsm 🎶🎤|🐱mom|she/her⚜️🏠#504 tweetsmyown